Literature DB >> 25879626

Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory Circuit.

Yanning Li1, Demei Liu2, Yanhong Zong2, Jinsheng Qi2, Bin Li2, Kun Liu2, Hui Xiao2.   

Abstract

On the basis of their characteristics, we presume that developmental stage-specific hepatocytes should have the ability to induce maturation of hepatoma cells. A regulatory circuit formed by hepatocyte nuclear factor (HNF)-4α, HNF-1α, HNF-6 and the upstream stimulatory factor (USF-1) play a key role in the maturation of embryonic hepatocytes; however, it is unclear whether the regulatory circuit mediates the embryonic induction of hepatoma cell maturation. In this study, 12.5-d to 15.5-d mouse embryonic hepatocytes or their medium were used to coculture or treat HepG2 cells, and the induced maturation was evaluated in vitro and in vivo. In the induced HepG2 cells, the components of the regulatory circuit were detected, their cross-regulation was evaluated and HNF-4α RNA interference was performed. We found that 13.5-d to 14.5-d embryonic hepatocytes could induce HepG2 cell maturation, demonstrated by morphological changes, increased maturation markers and decreased c-Myc and α-fetoprotein (AFP) in vitro. The majority of HepG2 tumors were eliminated by 13.5-d embryonic induction in vivo. All components of the regulatory circuit were upregulated and the binding of HNF-4α, HNF-1α, HNF-6 and USF-1 to their target sites was promoted to rebuild the regulatory circuit in the induced HepG2 cells. Moreover, RNA interference targeting HNF-4α, which is the core of the regulatory circuit, attenuated the induced maturation of HepG2 cells with downregulation of the regulatory circuit. These results revealed that developmental stage-specific hepatocytes could induce the maturation of HepG2 cells by rebuilding the regulatory circuit.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25879626      PMCID: PMC4503656          DOI: 10.2119/molmed.2014.00173

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  46 in total

1.  Differentiation therapy exerts antitumor effects on stem-like glioma cells.

Authors:  Benito Campos; Feng Wan; Mohammad Farhadi; Aurélie Ernst; Felix Zeppernick; Katrin E Tagscherer; Rezvan Ahmadi; Jennifer Lohr; Christine Dictus; Georg Gdynia; Stephanie E Combs; Violaine Goidts; Burkhard M Helmke; Volker Eckstein; Wilfried Roth; Philipp Beckhove; Peter Lichter; Andreas Unterberg; Bernhard Radlwimmer; Christel Herold-Mende
Journal:  Clin Cancer Res       Date:  2010-05-04       Impact factor: 12.531

Review 2.  Risk of HCC: genetic heterogeneity and complex genetics.

Authors:  Tommaso A Dragani
Journal:  J Hepatol       Date:  2009-11-24       Impact factor: 25.083

3.  Threshold levels of hepatocyte nuclear factor 6 (HNF-6) acting in synergy with HNF-4 and PGC-1alpha are required for time-specific gene expression during liver development.

Authors:  Jean-Bernard Beaudry; Christophe E Pierreux; Graham P Hayhurst; Nicolas Plumb-Rudewiez; Mary C Weiss; Guy G Rousseau; Frédéric P Lemaigre
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.

Authors:  Sulin Wu; Rebecca Mar-Heyming; Eric Z Dugum; Nicholas A Kolaitis; Hongxiu Qi; Päivi Pajukanta; Lawrence W Castellani; Aldons J Lusis; Thomas A Drake
Journal:  Hum Mol Genet       Date:  2009-12-08       Impact factor: 6.150

5.  Peroxynitrite-induced nitration of cyclooxygenase-2 and inducible nitric oxide synthase promotes their binding in diabetic angiopathy.

Authors:  Yanning Li; Jinsheng Qi; Kun Liu; Bin Li; Hui Wang; Jinhai Jia
Journal:  Mol Med       Date:  2010-06-30       Impact factor: 6.354

6.  Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma.

Authors:  Lantu Gou; Wei Wang; Aiping Tong; Yuqin Yao; Yan Zhou; Cheng Yi; Jinliang Yang
Journal:  J Mol Med (Berl)       Date:  2011-04-08       Impact factor: 4.599

Review 7.  Generation and regeneration of cells of the liver and pancreas.

Authors:  Kenneth S Zaret; Markus Grompe
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

8.  Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Authors:  Shunsuke Muramatsu; Shinji Tanaka; Kaoru Mogushi; Rama Adikrisna; Arihiro Aihara; Daisuke Ban; Takanori Ochiai; Takumi Irie; Atsushi Kudo; Noriaki Nakamura; Koh Nakayama; Hiroshi Tanaka; Shoji Yamaoka; Shigeki Arii
Journal:  Hepatology       Date:  2013-05-27       Impact factor: 17.425

Review 9.  A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.

Authors:  P M Biava; A Nicolini; P Ferrari; A Carpi; S Sell
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.

Authors:  Yi Tang; Krit Kitisin; Wilma Jogunoori; Cuiling Li; Chu-Xia Deng; Susette C Mueller; Habtom W Ressom; Asif Rashid; Aiwu Ruth He; Jonathan S Mendelson; John M Jessup; Kirti Shetty; Michael Zasloff; Bibhuti Mishra; E P Reddy; Lynt Johnson; Lopa Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

View more
  2 in total

1.  Decellularized human liver extracellular matrix (hDLM)-mediated hepatic differentiation of human induced pluripotent stem cells (hIPSCs).

Authors:  Maria Jaramillo; Heidi Yeh; Martin L Yarmush; Basak E Uygun
Journal:  J Tissue Eng Regen Med       Date:  2018-01-21       Impact factor: 3.963

2.  Tongxinluo Reverses the Hypoxia-suppressed Claudin-9 in Cardiac Microvascular Endothelial Cells.

Authors:  Kun Liu; Xiu-Juan Wang; Yan-Ning Li; Bin Li; Jin-Sheng Qi; Jing Zhang; Yu Wang
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.